MarkoIvoKlisovicMD

PubMed

• 57 citations
  A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
  Rebecca B. Klisovic, Wendy Stock, Spero R. Cataland, Marko I. Klisovic, Shujun Liu, William Blum, Margaret Green, Olatoyosi Odenike, Lucy A. Godley, Jennifer Vanden Bu...> ;Clinical Cancer Research. 2008 Apr 15
• 100 citations
  The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
  Susan P. Whitman, Shujun Liu, Tamara Vukosavljevic, Laura J. Rush, Li Yu, Chunhui Liu, Marko I. Klisovic, Kati Maharry, Martin Guimond, Matthew P. Strout, Brian Beckne...> ;Blood. 2005 Jul 1
• 30 citations
  Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.
  Dino D. Klisovic, Marko I. Klisovic, David Effron, Shujun Liu, Guido Marcucci, Steven E. Katz> ;Melanoma Research. 2005 Jun 1
• 107 citations
  Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Ac...
  Guido Marcucci, Wendy Stock, Guowei Dai, Rebecca B. Klisovic, Shujun Liu, Marko I. Klisovic, William Blum, Cheryl Kefauver, Dorie Sher, Margaret Green, Mollie E. Moran...> ;Journal of Clinical Oncology. 2005 May 20
• 34 citations
  Cellular Uptake and Intracellular Levels of the Bcl-2 Antisense G3139 in Cultured Cells and Treated Patients with Acute Myeloid Leukemia
  Guowei Dai, Kenneth K. Chan, Shujun Liu, Dale G. Hoyt, Susan P. Whitman, Marko I. Klisovic, Tiansheng Shen, Michael A. Caligiuri, John C. Byrd, Michael R. Grever, Guid...> ;Clinical Cancer Research. 2005 Apr 15
• 113 citations
  Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
  Shujun Liu, Tiansheng Shen, Lenguyen Huynh, Marko I. Klisovic, Laura J. Rush, Jamie L. Ford, Jianhua Yu, Brian Becknell, Yu Li, Chunhui Liu, Tamara Vukosavljevic, Susa...> ;Cancer Research. 2005 Feb 15
• 48 citations
  Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography...
  Liwen Zhang, Michael A. Freitas, Joseph Wickham, Mark R. Parthun, Marko I. Klisovic, Guido Marcucci, John C. Byrd> ;Journal of the American Society for Mass Spectrometry. 2003 Nov 14
• 47 citations
  Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines
  Dino D. Klisovic, Steven E. Katz, David Effron, Marko I. Klisovic, Joseph Wickham, Mark R. Parthun, Martin Guimond, Guido Marcucci> ;Investigative Ophthalmology & Visual Science. 2003 Jun 1
• 163 citations
  Chipping away at the chip bias: RNA degradation in microarray analysis.
  Herbert Auer, Lyianarachchi S, David L. Newsom, Marko I. Klisovic, Guido Marcucci, Karl Kornacker> ;Nature Genetics. 2003 Dec 1
• 113 citations
  Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-posit...
  Marko I. Klisovic, E. A. Maghraby, Mark R. Parthun, Martin Guimond, Amy R. Sklenar, Susan P. Whitman, Kenneth K. Chan, T. Murphy, J. Anon, Kellie J. Archer, Laura J. R...> ;Leukemia. 2003 Feb 1
• 155 citations
  Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
  Guido Marcucci, John C. Byrd, Guowei Dai, Marko I. Klisovic, Peter J. Kourlas, Donn C. Young, Spero R. Cataland, Diane B. Fisher, David M. Lucas, Kenneth Chan, Pierlui...> ;Blood. 2003 Jan 15
• G3139, a BCL-2 antisense oligo-nucleotide, in AML.
  Marcucci, G., Stock, W., Dai, G., Klisovic, M. I., Maharry, K., Shen, T., Liu, S., Sher, D. A., Lucas, D., Zwiebel, A., Larson, R. A., Caligiuri, M. A., Bloomfield, C....> ;Ann Hematol. 2004
• Join now to see all